STOCKS TELEGRAPH

Tag: GMVD stock

  • G Medical Innovations Holdings Ltd (GMVD) gained in the Pre-market; here is why?

    G Medical Innovations Holdings Ltd (GMVD) gained in the Pre-market; here is why?

    G Medical Innovations Holdings Ltd (GMVD) stock gained in the pre-market following the news of its announcement in a press release about its $12 million private placement. GMVD values at $5.40, gaining more than 9% from the previously closed value. The stock closed at $4.94 at the end of the previous trading session. The stock volume traded in the last trading session was approximately 3.81 million shares.

    GMVD announced a $12 million private placement

    An announcement was made today by G Medical Innovations Holdings Ltd (GMVD) confirming a securities purchase agreement with a single institutional investor.

    An additional 2,400,000 ordinary shares will be issued in a private placement. Preliminary estimates indicate that the purchase price per common shares and a related warrant will be $5.00, resulting in estimated gross earnings of about $12 million, before excluding placement agent fees and other offering costs paid by the Company. Upon issuance, the warrants will have an exercise price of $5.00 per ordinary share, will be exercisable instantly, and have an expiration date of five years from the date of issuance.

    The private placement will close on or about February 2, 2022. According to the press release, the funds raised from the share sale would repay current loans and work capital.

    For the private placement, A.G.P./Alliance Global Partners serves as the sole placing agent on behalf of the underwriters.

    The effect on the GMVD stock

    The announcement of the private placement has a significant effect on the stock. Its stock surged in the pre-market. Pre-market is a volatile trading session as most investors trade in the regular trading session. Despite it, the investors were responding positively to the stock.

    Conclusion

    The company is looking forward to using the proceeding in different business operations. It will help them pay current loans and use the remaining cash as working capital.

  • G Medical Innovations Holdings Ltd. (GMVD) stock Succumbs to Corrections After Hours

    G Medical Innovations Holdings Ltd. (GMVD) stock Succumbs to Corrections After Hours

    On January 19, G Medical Innovations Holdings Ltd. (GMVD) stock fell under corrections after-hours following its huge gain in regular trading. The stock gained big on news of personal acquisitions of its shares in the open market.

    Consequently, GMVD gained 45.37% in regular trading, at its close of $6.12 on Wednesday. Following the gain, the stock lost 6.70% to corrections in the after-hours. Therefore, GMVD was trading at $5.71 apiece in the after-hours session.

    The Monitoring service platform and mobile & e-health solutions developer, G Medical Innovations Holdings Ltd. was founded in 2014. Currently, its 13.46 million outstanding shares trade at a market capitalization of $56.69 million.

    What Happened?

    On January 14, the announcement was made regarding the personal acquisition of the company’s shares. According to this, President and CEO of G Medical Innovations, Dr. Yacov Geva, and CEO of McDade Products, LLC, Micheal McDade, acquired an undisclosed number of GMVD shares.

    Today, a correction was announced to the previous press release stating the acquisition of the shares. As per the corrected press release, Dr. Geva and Mr. McDade intend to acquire the company’s shares during the next available window in the open market.

    Effect on GMVD Movement

    As a result of the corrected news, the GMVD stock gained hugely in regular trading. Hence, on December 19, the stock reached its new 52-week high of $6.74. The addition of 45.37% along with a new 52-week high caused the stock to enter corrections in the after-hours. Thus, the stock suffered a loss due to corrections for shedding its gains, in the after-hours on Wednesday.

    To analyze further, GMVD has added a notable 106.06% in the past five days alone. Moreover, the stock has increased by 266.47% year to date, while it added 74.83% last year.

    GMVD’s Financials

    On September 15, the company declared its financial report for the six months which ended on June 30, 2021.

    For the first half of 2021, the company reported total revenues of $2,925,000, against $2,010,000 for the first half of 2020. This marks an increase of 45.5% year over year.

    Furthermore, the net loss was $4,771,000 in the first half of 2021, against $4,981,000 in the year-ago six months’ period. Resultantly, the net loss per share basic and diluted share was $0.51 and $0.84 in the first half of 2021 and 2020, respectively. This shows a decrease of 39.3% year over year in the net loss.